{"id":138909,"date":"2025-08-12T05:53:13","date_gmt":"2025-08-12T05:53:13","guid":{"rendered":"https:\/\/www.europesays.com\/us\/138909\/"},"modified":"2025-08-12T05:53:13","modified_gmt":"2025-08-12T05:53:13","slug":"genetic-insights-into-causal-effects-of-lipids-and-lipid-modifying-targets-on-calcific-aortic-valve-stenosis-a-mendelian-randomized-study","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/138909\/","title":{"rendered":"Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study"},"content":{"rendered":"
  • \n

    Yadgir, S. et al. Global burden of disease study 2017 nonrheumatic valve disease collaborators. Global, regional, and National burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017. Circulation 141<\/b>, 1670\u20131680 (2020).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Baumgartner, H. et al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 38<\/b>, 2739\u20132791 (2017).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Smith, J. G. et al. Cohorts for heart and aging research in genetic epidemiology (CHARGE) extracoronary calcium working group. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA 312<\/b> (17), 1764\u20131771 (2014).<\/p>\n

    ADS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kaltoft, M., Langsted, A. & Nordestgaard, B. G. Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen general population study. Eur. Heart J. 41<\/b> (24), 2288\u20132299 (2020).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nazarzadeh, M. et al. Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study. Eur. Heart J. 41<\/b> (40), 3913\u20133920 (2020).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Cowell, S. J. et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl. J. Med. 352<\/b>, 2389\u20132397 (2005).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Rosseb\u00f8, A. B. et al. Intensive lipid Lowering with Simvastatin and Ezetimibe in aortic stenosis. N Engl. J. Med. 359<\/b>, 1343\u20131356 (2008).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A. & Tam, J. ASTRONOMER investigators. Effect of lipid Lowering with Rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of Rosuvastatin (ASTRONOMER) trial. Circulation 121<\/b>, 306\u2013314 (2010).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Moore, M. K., Jones, G. T., McCormick, S., Williams, M. J. A. & Coffey, S. Association between\u2002lipoprotein(a), LPA genetic risk score,\u2002aortic\u2002valve\u2002disease, and subsequent major adverse cardiovascular events. Eur. J. Prev. Cardiol. 31<\/b> (10), 1303\u20131311 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Satterfield, B. A. et al. Associations of genetically predicted Lp(a) (Lipoprotein\u2002[a]) levels with cardiovascular traits in individuals of European and African ancestry. Circ. Genom Precis Med. 14<\/b> (4), e003354 (2021).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Arsenault, B. J. et al. Lipoprotein(a) and calcific aortic valve stenosis progression: A systematic review and Meta-Analysis. JAMA Cardiol. 9<\/b> (9), 835\u2013842 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Primers. 2<\/b> (1), 6 (2022).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ference, B. A. et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl. J. Med. 375<\/b> (22), 2144\u20132153 (2016).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Williams, D. M., Finan, C., Schmidt, A. F., Burgess, S. & Hingorani, A. D. Lipid Lowering and alzheimer disease risk: a Mendelian randomization study. Ann. Neurol. 87<\/b> (1), 30\u201339 (2020).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Fang, S. et al. Richardson tg.association between genetically proxied PCSK9 Inhibition and prostate cancer risk: A Mendelian randomisation study. PLoS Med. 20<\/b> (1), e1003988 (2023).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yu Chen, H. et al. Dyslipidemia,\u2002inflammation,\u2002calcification, and\u2002adiposity\u2002in\u2002aortic\u2002stenosis: a\u2002genome-wide\u2002study. Eur. Heart J. 44<\/b> (21), 1927\u20131939 (2023).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Small, A. M. et al. Multiancestry Genome-Wide association study of aortic stenosis identifies multiple novel loci in the million veteran program. Circulation 147<\/b> (12), 942\u2013955 (2023).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326<\/b> (16), 1614\u20131621 (2021).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature 600<\/b>, 675\u2013679 (2021).<\/p>\n

    ADS<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613<\/b> (7944), 508\u2013518 (2023).<\/p>\n

    ADS<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Mach, F. et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41<\/b> (1), 111\u2013188 (2020).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 139<\/b> (25), e1082\u2013e1143 (2019). <\/p>\n<\/li>\n

  • \n

    Bor\u00e9n, J., Taskinen, M. R., Bj\u00f6rnson, E. & Packard, C. J. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia. Nat. Rev. Cardiol. 19<\/b> (9), 577\u2013592 (2022).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Woolf, B. et al. A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: Mendelian randomisation study. BMJ 383<\/b>, e076197 (2023).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53<\/b>, 1712\u20131721 (2021).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374<\/b>, eabj1541 (2021).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature 622<\/b> (7982), 329\u2013338 (2023).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    The GTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science 369<\/b> (6509), 1318\u20131330 (2020).<\/p>\n

    PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10<\/b> (5), e1004383 (2014).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Morrison, J. et al. Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat. Genet. 52<\/b>, 740\u2013747 (2020).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Staiger, D. & Stock, J. H. Instrumental variables regression with weak instruments. Econometrica 65<\/b> (3), 557\u2013586 (1997).<\/p>\n

    MathSciNet<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sanderson, E. Multivariable Mendelian randomization and mediation. Cold Spring Harb Perspect. Med. 11<\/b> (2), a038984 (2021).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Richardson, T. G. et al. Characterising metabolomic signatures of lipid-modifying therapies through drug target Mendelian randomisation. PLoS Biol. 20<\/b> (2), e3001547 (2022).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Wang, Q. et al. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis. Eur. Heart J. 42<\/b> (12), 1160\u20131169 (2021).<\/p>\n

    ADS<\/a>\u00a0
    \n     CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Salaun, E. et al. Hemodynamic deterioration of surgically implanted bioprosthetic aortic valves. J. Am. Coll. Cardiol. 72<\/b>, 241\u2013251 (2018).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Nsaibia, M. J. et al. Association between plasma lipoprotein levels and bioprosthetic valve structural degeneration. Heart 102<\/b>, 1915 (2016).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Perrot, N. et al. Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis. JACC Basic. Transl Sci. 5<\/b> (7), 649\u2013661 (2020).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Poggio, P. et al. PCSK9 involvement in aortic valve calcification. J. Am. Coll. Cardiol. 72<\/b>, 3225\u20133227 (2018).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    R\u00e4m\u00f6, J. et al. Rare genetic variants in\u2002ldlr,\u2002apob, and\u2002PCSK9\u2002are associated with aortic stenosis. Circulation 150<\/b> (22), 1767\u20131780 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kjeldsen, E. W. et al. Cardiovascular risk factors and\u2002aortic\u2002valve\u2002stenosis: towards 10-year absolute risk charts for primary prevention. Eur. J. Prev. Cardiol. https:\/\/doi.org\/10.1093\/eurjpc\/zwae177<\/a> (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Larsson, S. C., Wolk, A., H\u00e5kansson, N. & B\u00e4ck, M. Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies. Eur. Heart J. 38<\/b> (28), 2192\u20132197 (2017).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Kaltoft, M., Langsted, A. & Nordestgaard, B. G. Obesity as a causal risk factor for aortic valve stenosis. J. Am. Coll. Cardiol. 75<\/b>, 163\u2013176 (2020).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    O\u2019Donoghue, M. L. et al. Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: insights from the FOURIER trial. Circulation 139<\/b>, 1483\u20131492 (2019).<\/p>\n

    PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    O’Brien, KD et al. Apolipoproteins\u2002B, (a), and E accumulate in the morphologically early lesion of \u2018degenerative\u2019 valvular\u2002aortic\u2002stenosis. Arterioscler. Thromb. Vasc Biol. 16<\/b> (4), 523\u2013532 (1996).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Siudut, J. et al. Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe\u2002aortic\u2002stenosis. Atherosclerosis 344<\/b>, 49\u201356 (2022).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Hou, Y. et al. Genetic proxy of lipid-lowering drugs and calcific aortic valve stenosis: A Mendelian randomization study. Heliyon 10<\/b> (13), e34089 (2024).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Yang, L. et al. Causal relationships between Lipid-Lowering drug target and aortic disease and calcific aortic valve stenosis: A Two-Sample Mendelian randomization. Rev. Cardiovasc. Med. 25<\/b> (8), 292 (2024).<\/p>\n

    PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Xu, D. et al. Identifying novel drug targets for calcific aortic valve disease through Mendelian randomization. Atherosclerosis 402<\/b>, 119110 (2025).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Temel, R. E. et al. Hepatic Niemann- pick C1- like 1 regulates biliary cholesterol concentration and is a target of Ezetimibe. J. Clin. Invest. 117<\/b>, 1968\u20131978 (2007).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n     PubMed Central<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Sudhop, T. et al. Inhibition of intestinal cholesterol absorption by Ezetimibe in humans. Circulation 106<\/b>, 1943\u20131948 (2002).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Arsenault, B. J. et al. Lipoprotein(a)\u2002levels,\u2002genotype, and\u2002incident\u2002aortic\u2002valve\u2002stenosis: a prospective Mendelian randomization study and replication in a case-control cohort. Circ. Cardiovasc. Genet. 7<\/b> (3), 304\u2013310 (2014).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Bhatia, H. S. et al. Oxidized phospholipids and calcific aortic valvular disease. J. Am. Coll. Cardiol. 84<\/b> (25), 2430\u20132441 (2024).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n

  • \n

    Robinson, J. G. et al. Efficacy and safety of Alirocumab in reducing lipids and cardiovascular events. N Engl. J. Med. 372<\/b> (16), 1489\u20131499 (2015).<\/p>\n

    CAS<\/a>\u00a0
    \n     PubMed<\/a>\u00a0
    \n
    \n Google Scholar<\/a>\u00a0\n <\/p>\n<\/li>\n","protected":false},"excerpt":{"rendered":"Yadgir, S. et al. Global burden of disease study 2017 nonrheumatic valve disease collaborators. Global, regional, and National…\n","protected":false},"author":3,"featured_media":138910,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[83148,83145,26266,83152,815,29197,10046,83153,83147,83149,10047,83150,83151,10542,159,67,132,68,83146],"class_list":{"0":"post-138909","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-calcific-aortic-valve-stenosis","9":"tag-cardiovascular-genetics","10":"tag-epidemiology","11":"tag-eqtl","12":"tag-genetics","13":"tag-genetics-research","14":"tag-humanities-and-social-sciences","15":"tag-ldl-c","16":"tag-lipids-profile","17":"tag-mendelian-randomization","18":"tag-multidisciplinary","19":"tag-pcsk9","20":"tag-pqtl","21":"tag-risk-factors","22":"tag-science","23":"tag-united-states","24":"tag-unitedstates","25":"tag-us","26":"tag-valvular-disease"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115014244985839574","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/138909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=138909"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/138909\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/138910"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=138909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=138909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=138909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}